BioStock Investor Meeting: Elicera Therapeutics presents
Gothenburg-based Elicera Therapeutics, headed by CEO Jamal El-Mosleh, travelled to Stockholm to present the company at the BioStock Investor Meeting. The cell and gene therapy company has developed a universal CAR T-cell-enhancement technology platform called iTANK (ImmunoTherapies Activated with NAP for efficient Killing) to be used in the fight against cancer.
See Elicera Therapeutics’ presentation below.
